On July 30 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA has issued its weekly Enforcement Report for July 28, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
FDA set potential fiscal year 2022 fees for import reinspections, domestic and foreign facility reinspections, and recall activities the agency performs if a firm fails to comply with a mandatory recall order, though it still isn't invoicing for services associated with the fees, it said in a notice released July 27. The agency set FY22 fees of $277 per hour for domestic services involving travel and $330 hourly if foreign travel is required.
FDA will set the fiscal year 2022 fee for its Voluntary Qualified Import Program at $15,938, it said in a notice. The fee, which is down from $17,000 last year, is required from food importers to begin participation in the VQIP trusted trader program for the period beginning Oct. 1, 2021, FDA said. The fee will remain in effect through Sept. 30, 2022, it said. FDA approved three importers for participation in VQIP for fiscal year 2021 (see 2011300052).
FDA is working with CBP to conduct a pilot on the use of blockchain and cloud technologies to trace food supply chains “from farm to importation,” said Dawne Hines, director of the FDA Division of Northeast Imports, July 22 during CBP’s Virtual Trade Week. The proof of concept aims to aid “government to government communications,” reduce data duplication and move toward the future elimination of paper, she said.
On July 23 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA has issued its weekly Enforcement Report for July 21, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
On July 22 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On July 21 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On July 20 FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of: